View ValuationChemed 将来の成長Future 基準チェック /06Chemedは、7.4%と5.1%でそれぞれ年率7.4%で利益と収益が成長すると予測される一方、EPSはgrowで10.9%年率。主要情報7.4%収益成長率10.85%EPS成長率Healthcare 収益成長31.0%収益成長率5.1%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日21 Sep 2025今後の成長に関する最新情報お知らせ • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.お知らせ • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.お知らせ • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.すべての更新を表示Recent updatesお知らせ • Jul 01Chemed Corporation to Report Q2, 2026 Results on Jul 28, 2026Chemed Corporation announced that they will report Q2, 2026 results After-Market on Jul 28, 2026お知らせ • Jun 29+ 6 more updatesChemed Corporation(NYSE:CHE) dropped from Russell Small Cap Comp Growth BenchmarkChemed Corporation(NYSE:CHE) dropped from Russell Small Cap Comp Growth Benchmarkお知らせ • May 20Chemed Corporation Declares Quarterly Cash Dividend, Payable on June 16, 2026Chemed Corporation at the annual stockholders’ meeting held on May 18, 2026 declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026.お知らせ • Apr 07Chemed Corporation, Annual General Meeting, May 18, 2026Chemed Corporation, Annual General Meeting, May 18, 2026. Location: queen city club, 331 east fourth street, cincinnati, ohio, United Statesお知らせ • Apr 02Chemed Corporation to Report Q1, 2026 Results on Apr 23, 2026Chemed Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Apr 23, 2026お知らせ • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.お知らせ • Feb 14Chemed Corporation Declares Quarterly Cash Dividend, Payable on March 13, 2026Chemed Corporation announced the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.お知らせ • Jan 03Chemed Corporation to Report Q4, 2025 Results on Feb 25, 2026Chemed Corporation announced that they will report Q4, 2025 results After-Market on Feb 25, 2026お知らせ • Nov 07Chemed Corporation Declares Quarterly Cash Dividend, Payable on December 5, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025.お知らせ • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.お知らせ • Oct 01Chemed Corporation to Report Q3, 2025 Results on Oct 28, 2025Chemed Corporation announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Oct 28, 2025お知らせ • Aug 02Chemed Corporation Declares Quarterly Cash Dividend on Capital Stock, Payable on August 29, 2025The Board of Directors of Chemed Corporation has declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10 cents, or 20.0%, increase over the 50 cents dividend paid in June 2025.お知らせ • Jul 30+ 1 more updateChemed Corporation Announces Departure of Nicholas M. Westfall as Executive Vice President, Effective December 1, 2025Chemed Corporation (company) announced that after a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS Healthcare Corporation (VITAS), Nicholas M. Westfall, has announced that he is departing the company to pursue other personal and professional opportunities. Mr. Westfall will continue to work with the Company until December 1, 2025 to ensure an orderly transition. Mr. Westfall has been with Chemed since May 2009. He transitioned to the role of Senior Vice President of Operations at VITAS in 2012 and was promoted to Chief Operating Officer in 2015. Mr. Westfall has been serving as an Executive Vice President of Chemed and Chief Executive Officer of VITAS since June 2016 and was named Chairman and Chief Executive Officer of VITAS in 2024.お知らせ • Jun 28Chemed Corporation to Report Q2, 2025 Results on Jul 29, 2025Chemed Corporation announced that they will report Q2, 2025 results After-Market on Jul 29, 2025お知らせ • May 20Chemed Corporation Declares Quarterly Dividend, Payable on June 17, 2025Chemed Corporation declared a quarterly cash dividend of 50 cents per share on the Company’s capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed’s 54 years as a public company.お知らせ • Apr 03Chemed Corporation, Annual General Meeting, May 19, 2025Chemed Corporation, Annual General Meeting, May 19, 2025.お知らせ • Apr 01Chemed Corporation to Report Q1, 2025 Results on Apr 23, 2025Chemed Corporation announced that they will report Q1, 2025 results After-Market on Apr 23, 2025お知らせ • Feb 15Chemed Corporation Declares Quarterly Dividend, Payable on March 14, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025.お知らせ • Feb 12Chemed Corporation to Report Q4, 2024 Results on Feb 26, 2025Chemed Corporation announced that they will report Q4, 2024 results After-Market on Feb 26, 2025Recent Insider Transactions • Dec 03CEO, President & Director recently sold Mex$23m worth of stockOn the 25th of November, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,650 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth Mex$23m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$128m.お知らせ • Nov 08Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024Chemed Corporation declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214 consecutive quarterly dividend paid by Chemed in its 53 years as a public company.お知らせ • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.Recent Insider Transactions • Sep 28CEO, President & Director recently sold Mex$23m worth of stockOn the 26th of September, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,710 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$135m.お知らせ • Sep 14Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024Chemed Corporation announced that they will report Q3, 2024 results After-Market on Oct 29, 2024Recent Insider Transactions • Sep 11Executive Vice President recently sold Mex$19m worth of stockOn the 9th of September, Nicholas Westfall sold around 2k shares on-market at roughly Mex$11,323 per share. This transaction amounted to 22% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Insiders have been net sellers, collectively disposing of Mex$434m more than they bought in the last 12 months.業績と収益の成長予測BMV:CHE * - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20272,819N/AN/AN/A112/31/20262,720319383437412/31/20252,54927936842446/30/20252,512290371427N/A3/31/20252,489309315366N/A12/31/20242,431302368417N/A9/30/20242,377302313361N/A6/30/20242,336301253300N/A3/31/20242,293283302354N/A12/31/20232,264273273330N/A9/30/20232,225245259322N/A6/30/20232,187226280345N/A3/31/20232,165240208269N/A12/31/20222,135250253310N/A9/30/20222,129262220273N/A6/30/20222,141277284334N/A3/31/20222,142267249303N/A12/31/20212,139269250309N/A9/30/20212,132308271332N/A6/30/20212,121303283344N/A3/31/20212,091329450507N/A12/31/20202,080319430489N/A9/30/20202,069271410466N/A6/30/20202,021263413470N/A3/31/20201,992231258317N/A12/31/20191,939220248301N/A9/30/20191,874209238294N/A6/30/20191,837201218275N/A3/31/20191,806205N/A296N/A12/31/20181,783206N/A287N/A9/30/20181,753206N/A202N/A6/30/20181,727190N/A183N/A3/31/20181,700113N/A159N/A12/31/20171,66798N/A162N/A9/30/20171,64276N/A198N/A6/30/20171,61767N/A162N/A3/31/20171,592114N/A197N/A12/31/20161,577109N/A135N/A9/30/20161,572106N/A187N/A6/30/20161,566108N/A175N/A3/31/20161,557111N/A166N/A12/31/20151,543110N/A172N/A9/30/20151,524110N/A172N/A6/30/20151,496106N/A135N/A3/31/20151,475103N/A134N/A12/31/20141,45699N/A110N/A9/30/20141,42592N/A66N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CHE *の予測収益成長率 (年間7.4% ) は 貯蓄率 ( 8.5% ) を下回っています。収益対市場: CHE *の収益 ( 7.4% ) MX市場 ( 9.2% ) よりも低い成長が予測されています。高成長収益: CHE *の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: CHE *の収益 ( 5.1% ) MX市場 ( 6.2% ) よりも低い成長が予測されています。高い収益成長: CHE *の収益 ( 5.1% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CHE *の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/09/27 18:16終値2025/06/30 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Chemed Corporation 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関Adam FeinsteinBarclaysJoanna Sylvia GajukBofA Global ResearchPeter MartinCitizens JMP Securities, LLC7 その他のアナリストを表示
お知らせ • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.
お知らせ • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.
お知らせ • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.
お知らせ • Jul 01Chemed Corporation to Report Q2, 2026 Results on Jul 28, 2026Chemed Corporation announced that they will report Q2, 2026 results After-Market on Jul 28, 2026
お知らせ • Jun 29+ 6 more updatesChemed Corporation(NYSE:CHE) dropped from Russell Small Cap Comp Growth BenchmarkChemed Corporation(NYSE:CHE) dropped from Russell Small Cap Comp Growth Benchmark
お知らせ • May 20Chemed Corporation Declares Quarterly Cash Dividend, Payable on June 16, 2026Chemed Corporation at the annual stockholders’ meeting held on May 18, 2026 declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026.
お知らせ • Apr 07Chemed Corporation, Annual General Meeting, May 18, 2026Chemed Corporation, Annual General Meeting, May 18, 2026. Location: queen city club, 331 east fourth street, cincinnati, ohio, United States
お知らせ • Apr 02Chemed Corporation to Report Q1, 2026 Results on Apr 23, 2026Chemed Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Apr 23, 2026
お知らせ • Feb 26Chemed Corporation Provides Consolidated Earnings Guidance for the Year 2026Chemed Corporation provided consolidated earnings guidance for the year 2026. For the full-year 2026 earnings per diluted share, excluding non-cash expenses for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.25 to $24.25.
お知らせ • Feb 14Chemed Corporation Declares Quarterly Cash Dividend, Payable on March 13, 2026Chemed Corporation announced the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
お知らせ • Jan 03Chemed Corporation to Report Q4, 2025 Results on Feb 25, 2026Chemed Corporation announced that they will report Q4, 2025 results After-Market on Feb 25, 2026
お知らせ • Nov 07Chemed Corporation Declares Quarterly Cash Dividend, Payable on December 5, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025.
お知らせ • Oct 29Chemed Corporation Reiterates Earnings Guidance for the Year 2025Chemed Corporation reiterated earnings guidance for the year 2025. For the year, management reiterates its previously issued guidance of $22.00 to $22.30 per share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items.
お知らせ • Oct 01Chemed Corporation to Report Q3, 2025 Results on Oct 28, 2025Chemed Corporation announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Oct 28, 2025
お知らせ • Aug 02Chemed Corporation Declares Quarterly Cash Dividend on Capital Stock, Payable on August 29, 2025The Board of Directors of Chemed Corporation has declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10 cents, or 20.0%, increase over the 50 cents dividend paid in June 2025.
お知らせ • Jul 30+ 1 more updateChemed Corporation Announces Departure of Nicholas M. Westfall as Executive Vice President, Effective December 1, 2025Chemed Corporation (company) announced that after a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS Healthcare Corporation (VITAS), Nicholas M. Westfall, has announced that he is departing the company to pursue other personal and professional opportunities. Mr. Westfall will continue to work with the Company until December 1, 2025 to ensure an orderly transition. Mr. Westfall has been with Chemed since May 2009. He transitioned to the role of Senior Vice President of Operations at VITAS in 2012 and was promoted to Chief Operating Officer in 2015. Mr. Westfall has been serving as an Executive Vice President of Chemed and Chief Executive Officer of VITAS since June 2016 and was named Chairman and Chief Executive Officer of VITAS in 2024.
お知らせ • Jun 28Chemed Corporation to Report Q2, 2025 Results on Jul 29, 2025Chemed Corporation announced that they will report Q2, 2025 results After-Market on Jul 29, 2025
お知らせ • May 20Chemed Corporation Declares Quarterly Dividend, Payable on June 17, 2025Chemed Corporation declared a quarterly cash dividend of 50 cents per share on the Company’s capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed’s 54 years as a public company.
お知らせ • Apr 03Chemed Corporation, Annual General Meeting, May 19, 2025Chemed Corporation, Annual General Meeting, May 19, 2025.
お知らせ • Apr 01Chemed Corporation to Report Q1, 2025 Results on Apr 23, 2025Chemed Corporation announced that they will report Q1, 2025 results After-Market on Apr 23, 2025
お知らせ • Feb 15Chemed Corporation Declares Quarterly Dividend, Payable on March 14, 2025Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025.
お知らせ • Feb 12Chemed Corporation to Report Q4, 2024 Results on Feb 26, 2025Chemed Corporation announced that they will report Q4, 2024 results After-Market on Feb 26, 2025
Recent Insider Transactions • Dec 03CEO, President & Director recently sold Mex$23m worth of stockOn the 25th of November, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,650 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth Mex$23m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$128m.
お知らせ • Nov 08Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024Chemed Corporation declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214 consecutive quarterly dividend paid by Chemed in its 53 years as a public company.
お知らせ • Oct 30Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024Chemed Corporation revised consolidated earnings guidance for the full year 2024. For the full-year consolidated 2024 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation and other discrete items, is estimated to be in the range of $23.00 to $23.15. This range represents a 13.3% to 14.0% increase from it’s 2023 reported adjusted earnings per diluted share of $20.30.
Recent Insider Transactions • Sep 28CEO, President & Director recently sold Mex$23m worth of stockOn the 26th of September, Kevin McNamara sold around 2k shares on-market at roughly Mex$11,710 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Kevin has been a net seller over the last 12 months, reducing personal holdings by Mex$135m.
お知らせ • Sep 14Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024Chemed Corporation announced that they will report Q3, 2024 results After-Market on Oct 29, 2024
Recent Insider Transactions • Sep 11Executive Vice President recently sold Mex$19m worth of stockOn the 9th of September, Nicholas Westfall sold around 2k shares on-market at roughly Mex$11,323 per share. This transaction amounted to 22% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth Mex$53m. Insiders have been net sellers, collectively disposing of Mex$434m more than they bought in the last 12 months.